(Q44092524)

29 November 2017

title

Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour (English)

1 reference

29 November 2017

7

1 reference

29 November 2017

Dominique Baudry

1

0 references

Cécile Jeanpierre

object named as

Cécile Jeanpierre

10

0 references

Jean-Michel Zucker

5

object named as

Jean-Michel Zucker

1 reference

29 November 2017

Marine Faussillon

2

1 reference

29 November 2017

Marie-Odile Cabanis

3

1 reference

29 November 2017

Muriel Rigolet

4

1 reference

29 November 2017

Catherine Patte

6

1 reference

29 November 2017

Liliane Boccon-Gibod

8

1 reference

29 November 2017

Claudine Junien

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

21

1 reference

29 November 2017

issue

36

1 reference

29 November 2017

page(s)

5566-5573

1 reference

Donor splice-site mutations in WT1 are responsible for Frasier syndrome

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Life, sex, and WT1 isoforms--three amino acids can make all the difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Software and database for the analysis of mutations in the human WT1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

PCNA: structure, functions and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Physical and functional interaction between WT1 and p53 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

The Wilms' tumor suppressor WT1: approaches to gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Mesenchymal-epithelial transition in the developing metanephric kidney: gene expression study by differential display

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Profiling of differential gene expression in Wilms tumor by cDNA expression array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Truncation of WT1 results in downregulation of cyclin G1 and IGFBP-4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Proliferating cell nuclear antigen expression in Wilms' tumor: A comparative study of pre- and post-chemotherapy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

7 January 2021

Regulatory Actions of Insulin-like Growth Factor-binding Proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

7 January 2021

Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

7 January 2021

Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205752

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205752

1 reference

29 November 2017

1 reference